Industry tight-lipped on impact of FDA ER/LA opioid REMS
Manufacturers of extended-release and long-acting (ER/LA) opioids have declined to comment on the impact of a class-wide REMS.
Archives for July 18, 2012
ScinoPharm wins API contract for new US obesity drug Qsymia
Approval of Qsymia - Vivus’ anti-obesity drug – may be good news for the 35 per cent of US citizens classed as obese, but it is definitely good news for Taiwan-based CMO ScinoPharm.
Phyton gets CEP for paclitaxel production via plant-cell fermentation
API maker Phyton Biotech LLC has been granted a CEP for the production of paclitaxel using plant cell-based fermentation.